Bristol-Myers Squibb Company
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $16.21B | $15.23B | $973.0M | $583.0M |
| FY2022 | $13.07B | $11.95B | $1.12B | $457.0M |
| FY2023 | $13.86B | $12.65B | $1.21B | $518.0M |
| FY2024 | $15.19B | $13.94B | $1.25B | $507.0M |
| FY2025 | $14.16B | $12.85B | $1.31B | $553.0M |